Wird geladen...

Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins

The ability to selectively and directly target activated Ras would provide immense utility for treatment of the numerous cancers that are driven by oncogenic Ras mutations. Patients with disorders driven by overactivated wild-type Ras proteins, such as type 1 neurofibromatosis, might also benefit fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Mattingly, Raymond R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi Publishing Corporation 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833460/
https://ncbi.nlm.nih.gov/pubmed/24294527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/536529
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!